Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CAR-T Cancer Drugs Front And Center At ARM Investor Day

May 17 2017

• By Amanda Micklus

T-cells attacking cancer_1200x675

Related Content

CAR T-Cells, Helping US Firms & An “Ambitious” Plan For Advanced Therapies In The EU

Apr 10 2017

RAT Race Begins: FDA Accepting Regenerative Advanced Therapy Designation Requests

Jan 31 2017

BLA Accepted: Novartis Inches Ahead In CAR-T Race With Kite

Mar 30 2017

Juno Ends JCAR015 Development In ALL, Cementing Third Place CAR-T Position

Mar 02 2017

Kite Pharma Details CAR-T Therapy Launch, Floats Pricing Benchmarks

Oct 19 2016

Related Companies

Novartis AG

Kite Pharma, Inc.

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Bellicum Pharmaceuticals, Inc.

Johnson & Johnson

AbbVie Inc.

Amgen, Inc.

Massachusetts Institute of Technology

Massachusetts Institute of Technology

Additional Topics

Regenerative Medicine Commercial Market Access Cancer

More from Market Access

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window